All Type of News
Government to establish pricing criteria for efficacy-improved drugs
When an efficacy-improved drug gets listed for insurance coverage, the corresponding drug price will be determined in the same scope of the original drug whose patent was expired, the Ministry of Health and Welfare sa...
Drug makes struggling to set up next year's business plan
Tougher anticorruption measures to be slapped by the Fair Trade Commission (FTC), along with the government's relentless slash on drug prices, are casting a shadow over drug makers' business program next year, fueling...
Winner is visible in Dong-A's management battle
The current management of Dong-A Pharmaceutical led by its incumbent Chairman Kang Shin-ho will be likely to win a nearly three-year bitter struggle between Kang Moon-seok, who replaced his father Kang Shin-ho as the ...
KPMA chairman calls for fair drug pricing policy
Kim Chung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement that the government should work out measures to encourage drug companies to develop and market as many new drugs as possib...
Fair Trade Commission to slap fines on 10 pharmaceutical companies
The Fair Trade Commission (FTC) said on October 25 that 10 pharmaceutical firms have been found to provide hospitals and wholesalers with rebates or donations under various pretexts and that it will slap heavy fines o...
Local cold medicine market getting heated
With the winter season approaching in hand, local drug makers are biting into the domestic cold remedy market in hope of more proportions.
Some of the top three players, including Korean Drug, Hanil Pharm and Choon...
SeouLin seeks international hepatitis B test patent
SeouLin Bioscience, local biopharmaceutical firm, said it has filed an international patent application for detecting mutants of hepatitis B virus, a company official said.
The company's patent may be applicable in...
Current Dong-A management likely to win
Pharmaceutical sources says the current management led by its incumbent Chairman Kang Shin-ho will get more advantageous position as Mirae Asset Investments, the largest shareholder of Dong-A Pharmaceutical, announced...
Amino acid infusion makers struggling to boost bottom lines
The Korea's three drug makers for essential amino infusion Choongwae Pharm, CJ Corporation and Daehan Pharm - are finding it increasingly difficult to boost their bottom line amid extremely low prices compared with f...
Battle likely to get fiercer between pharmacy and supermarket
Pharmacists will roll up their sleeves to promote the advancement of large businesses into pharmacy sector for diversifying management, escalating controversy between pharmacists and supermarket owners.
When it was...
